Brajesh Kumar Agrawal, MD
Neurology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Agrawal’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Illinois 125052048Temporary Medical Permit · since 2009 · expires 2010-06-24Specialty on the licence: NeurologyExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$222,375
Medicare paid this office $222,375 for 351 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 29 | $64,455 | None |
| Long return visit (40+ min) | 95 | $21,209 | $159 |
| Muscle electrical test | 65 | $13,218 | $99 |
| New patient visit (60+ min) | 66 | $13,139 | $199 |
| Nerve test | 41 | $11,726 | $279 |
See all 21 services
| Botox | 29 | $64,455 | None |
| Long return visit (40+ min) | 95 | $21,209 | $159 |
| Muscle electrical test | 65 | $13,218 | $99 |
| New patient visit (60+ min) | 66 | $13,139 | $199 |
| Nerve test | 41 | $11,726 | $279 |
| Return visit (30+ min) | 61 | $9,212 | $114 |
| Short return visit (20+ min) | 43 | $7,799 | $82 |
| Face injection for nerve paralysis | 12 | $6,467 | $190 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 24 | $6,124 | $186 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 71 | $5,846 | $30 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 42 | $5,048 | $120 |
| Ultrasonic guidance for needle placement | 35 | $4,910 | $57 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 62 | $4,812 | $76 |
| Critical care, first 30-74 minutes | 11 | $4,760 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $4,517 | $105 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 179 | $3,994 | $15 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 12 | $3,678 | $119 |
| New patient visit (30+ min) | 33 | $3,337 | $101 |
| Nerve test | 14 | $3,156 | $225 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,002 | $150 |
| Short return visit | 14 | $780 | $52 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
351 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 18% · Women 61% · Also on Medicaid 17% · Health risk score 1.47. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Depression 32% · Chronic kidney disease 30% · Diabetes 29% · Dementia 28% · Coronary heart disease 26% · Atrial fibrillation 24% · Stroke 23% · Heart failure 22% · Cancer 13% · COPD 12%.
The office billed $875,042, Medicare allowed $284,841 and paid $222,375; for 16,124 services of 48 kinds; $69,763 of it was for drugs given in the office and $152,612 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 351 | 16,124 | 77 | 1.47 | $875,042 | $222,375 |
| 2023 | 334 | 14,257 | 76 | 1.54 | $788,250 | $206,200 |
| 2022 | 301 | 13,236 | 77 | 1.55 | $731,969 | $192,516 |
| 2021 | 284 | 7,654 | 77 | 1.38 | $574,976 | $155,791 |
| 2020 | 201 | 5,729 | 78 | 1.65 | $341,658 | $100,160 |
| 2019 | 250 | 3,132 | 77 | 1.59 | $380,696 | $112,266 |
| 2018 | 127 | 356 | 77 | 2.23 | $166,572 | $34,813 |
| 2017 | 142 | 242 | 67 | 2.05 | $166,177 | $16,850 |
| 2016 | 189 | 295 | 64 | 1.96 | $165,198 | $18,375 |
| 2015 | 85 | 118 | 62 | 1.78 | $48,151 | $7,933 |
| 2014 | 331 | 9,790 | 66 | 1.60 | $351,484 | $96,094 |
| 2013 | 545 | 18,576 | 68 | 1.76 | $670,649 | $169,604 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Botox | 30 | $55,318 | None |
| Long return visit (40+ min) | 68 | $15,112 | $151 |
| Nerve test | 51 | $14,432 | $278 |
| Muscle electrical test | 61 | $12,610 | $101 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 39 | $10,103 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $9,175 | $108 |
| Return visit (30+ min) | 54 | $8,425 | $120 |
| Short return visit (20+ min) | 41 | $7,533 | $83 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 91 | $7,512 | $77 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 24 | $6,949 | $248 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 41 | $6,291 | $121 |
| Critical care, first 30-74 minutes | 13 | $4,926 | $189 |
| Ultrasonic guidance for needle placement | 34 | $4,819 | $57 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 13 | $4,566 | $127 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 18 | $4,179 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,619 | $157 |
| New patient visit (60+ min) | 13 | $2,704 | $208 |
| New patient visit (45+ min) | 13 | $2,033 | $156 |
| New patient visit (30+ min) | 14 | $1,504 | $107 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | $612 | $29 |
2022: 16 services
| Botox | 32 | $56,072 | None |
| Long return visit (40+ min) | 93 | $23,655 | $157 |
| Nerve test | 49 | $14,924 | $287 |
| Muscle electrical test | 60 | $12,761 | $102 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 28 | $9,386 | $184 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 98 | $7,901 | $77 |
| Short return visit (20+ min) | 36 | $7,270 | $86 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 24 | $7,256 | $250 |
| Ultrasonic guidance for needle placement | 38 | $5,030 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,940 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,222 | $176 |
| Return visit (30+ min) | 25 | $3,879 | $114 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 14 | $3,843 | $133 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 12 | $3,747 | $139 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 21 | $2,563 | $122 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 30 | $951 | $28 |
2021: 15 services
| Botox | 18 | $30,719 | None |
| Long return visit (40+ min) | 85 | $22,302 | $164 |
| Nerve test | 43 | $12,586 | $293 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 32 | $12,301 | $189 |
| Muscle electrical test | 43 | $9,247 | $105 |
| Return visit (30+ min) | 54 | $7,644 | $109 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 94 | $7,633 | $79 |
| New patient visit (60+ min) | 34 | $6,939 | $204 |
| Critical care, first 30-74 minutes | 13 | $6,839 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $5,790 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,451 | $178 |
| Short return visit (20+ min) | 26 | $4,205 | $82 |
| Ultrasonic guidance for needle placement | 28 | $2,921 | $51 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 18 | $2,124 | $118 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 28 | $1,019 | $30 |
2020: 15 services
| Botox | 18 | $23,522 | None |
| Long return visit (40+ min) | 62 | $9,863 | $120 |
| Nerve test | 29 | $8,587 | $296 |
| Return visit (30+ min) | 51 | $7,994 | $102 |
| Extended patient service without direct patient contact, first hour | 61 | $7,450 | $102 |
| Muscle electrical test | 29 | $5,455 | $99 |
| New patient visit (60+ min) | 29 | $5,288 | $182 |
| Short return visit (20+ min) | 43 | $4,654 | $71 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 13 | $3,830 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,712 | $186 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 44 | $3,617 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,979 | $96 |
| New patient visit (45+ min) | 17 | $2,502 | $147 |
| Muscle electrical test | 15 | $1,748 | $83 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 11 | $1,253 | $114 |
2019: 14 services
| Long return visit (40+ min) | 61 | $13,258 | $135 |
| Extended patient service without direct patient contact, first hour | 89 | $11,009 | $100 |
| Muscle electrical test | 43 | $8,781 | $93 |
| Critical care, first 30-74 minutes | 19 | $7,880 | $197 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 86 | $7,156 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $7,068 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,867 | $178 |
| New patient visit (45+ min) | 35 | $5,267 | $150 |
| New patient visit (60+ min) | 28 | $5,247 | $187 |
| Return visit (30+ min) | 35 | $4,546 | $103 |
| Nerve test | 19 | $3,665 | $193 |
| Short return visit (20+ min) | 18 | $1,560 | $71 |
| New patient visit (30+ min) | 13 | $1,332 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,180 | $66 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $11,753 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,486 | $166 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,319 | $119 |
| Long return visit (40+ min) | 15 | $2,921 | $127 |
| New patient visit (45+ min) | 13 | $1,881 | $145 |
| Return visit (30+ min) | 16 | $1,872 | $94 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 21 | $1,694 | $77 |
| Short return visit (20+ min) | 14 | $1,005 | $67 |
| Short return visit | 18 | $946 | $41 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $4,161 | $90 |
| Return visit (30+ min) | 52 | $3,242 | $48 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,157 | $117 |
| Measurement of brain wave activity (eeg), awake and drowsy | 11 | $524 | $48 |
| Short return visit (20+ min) | 19 | $495 | $25 |
2016: 5 services
| Return visit (30+ min) | 84 | $6,676 | $57 |
| Measurement of brain wave activity (eeg), awake and drowsy | 36 | $1,834 | $50 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,822 | $121 |
| Short return visit (20+ min) | 46 | $1,603 | $29 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,365 | $76 |
2015: 3 services
| Return visit (30+ min) | 41 | $3,378 | $64 |
| Measurement of brain wave activity (eeg), awake and drowsy | 14 | $755 | $50 |
| Short return visit (20+ min) | 15 | $580 | $39 |
2014: 14 services
| Botox | 19 | $34,528 | None |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 79 | $8,727 | $108 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 28 | $8,555 | $25 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $6,932 | $81 |
| Return visit (30+ min) | 38 | $3,491 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $2,408 | $56 |
| Short return visit (20+ min) | 43 | $2,101 | $45 |
| Measurement of brain wave activity (eeg), awake and asleep | 47 | $2,067 | $43 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 22 | $2,063 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,590 | $80 |
| Muscle electrical test | 16 | $1,228 | $51 |
| Muscle electrical test | 19 | $1,215 | $64 |
| Measurement of brain wave activity (eeg), awake and drowsy | 23 | $1,033 | $45 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 28 | $1,003 | $36 |
2013: 27 services
| Botox | 28 | $68,002 | None |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 41 | $14,365 | $20 |
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 14 | $7,040 | $251 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $5,774 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $5,670 | $78 |
| Long return visit (40+ min) | 45 | $5,517 | $94 |
| Measurement of brain wave activity (eeg), awake and asleep | 100 | $4,445 | $43 |
| Injection of chemical for destruction of neck muscles | 13 | $3,906 | $126 |
| Muscle electrical test | 34 | $3,838 | $63 |
| Return visit (30+ min) | 48 | $3,644 | $65 |
| Injection of chemical for destruction of arms legs and/or torso muscles | 13 | $3,548 | $127 |
| Nerve test | 18 | $3,122 | $156 |
| Nerve test | 24 | $3,102 | $129 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 38 | $2,916 | $77 |
| Muscle electrical test | 32 | $2,879 | $45 |
| Measurement of brain wave activity (eeg), awake and drowsy | 64 | $2,757 | $43 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 26 | $2,559 | $91 |
| Short return visit (20+ min) | 49 | $2,352 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $2,337 | $54 |
| Muscle electrical test | 18 | $1,759 | $55 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 46 | $1,706 | $35 |
| New patient visit (45+ min) | 13 | $1,609 | $124 |
| Nerve test | 13 | $1,365 | $105 |
| Muscle electrical test | 20 | $1,249 | $62 |
| Measurement of brain wave activity (eeg), in coma or asleep | 22 | $1,001 | $44 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $859 | $30 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 11 | $766 | $70 |
Medicaid work
$884 in 2019
Medicaid paid $884 for 12 billed services this clinician did in 2019, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electroencephalogram (EEG) extended monitoring; 61-119 minutes | 12 | $884 |
| 2019 | 12 | 1 | 12 | $884 |
| 2018 | 13 | 1 | 13 | $951 |
See the largest Medicaid services in earlier years
2018
| Electroencephalogram (EEG) extended monitoring; 61-119 minutes | 13 | $951 |
Drugs they prescribed that Part D paid
$113,522
Pharmacies billed $113,522 in 2024. Most of that is one immune-globulin drugs at about $3,000 a fill for a small number of people.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 267) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
230 generic and 37 brand-name prescriptions · $113,522 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gamunex-C | Immune globulin | 33 | $99,693 | $3,021 |
| Memantine | None | 50 | $2,152 | $43 |
| Rivastigmine | None | 20 | $1,586 | $79 |
| Gabapentin | None | 20 | $450 | $23 |
| Primidone | None | 19 | $359 | $19 |
See all 7 drugs
| Gamunex-C | Immune globulin | 33 | $99,693 | $3,021 |
| Memantine | None | 50 | $2,152 | $43 |
| Rivastigmine | None | 20 | $1,586 | $79 |
| Gabapentin | None | 20 | $450 | $23 |
| Primidone | None | 19 | $359 | $19 |
| Divalproex | None | 12 | $266 | $22 |
| Levetiracetam | None | 11 | $211 | $19 |
Year by year
| 2024 | 267 | 75 | 0% (0) | 14% | $113,522 |
| 2023 | 672 | 131 | 0% (0) | 8% | $92,486 |
| 2022 | 895 | 149 | None | 12% | $196,137 |
| 2021 | 707 | 140 | None | 8% | $104,753 |
| 2020 | 535 | 119 | 0% (0) | 9% | $84,164 |
| 2019 | 461 | 101 | 0% (0) | 17% | $61,054 |
| 2018 | 207 | 55 | 0% (0) | 11% | $24,623 |
| 2017 | 1,137 | 153 | 0% (0) | 14% | $434,221 |
| 2016 | 2,347 | 274 | 0% (0) | 13% | $589,390 |
| 2015 | 1,113 | 260 | None | 14% | $283,493 |
| 2014 | 423 | 70 | 3% (11) | None | $25,249 |
| 2013 | 477 | 78 | None | None | $28,467 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Aimovig | Migraine | 12 | $9,451 | $788 |
| Ajovy | None | 11 | $8,297 | $754 |
| Memantine | None | 61 | $4,290 | $70 |
| Pregabalin | None | 64 | $3,870 | $60 |
| Rivastigmine | None | 29 | $2,258 | $78 |
| Levetiracetam | None | 33 | $2,243 | $68 |
| Gabapentin | None | 104 | $1,793 | $17 |
| Venlafaxine Hcl Er | None | 18 | $1,110 | $62 |
| Divalproex Sodium Er | None | 14 | $816 | $58 |
| Divalproex | None | 31 | $816 | $26 |
| Propranolol Hcl Er | None | 12 | $673 | $56 |
| Rizatriptan | None | 18 | $633 | $35 |
| Primidone | None | 24 | $576 | $24 |
| Duloxetine | None | 19 | $495 | $26 |
| Escitalopram | None | 24 | $363 | $15 |
| Donepezil | None | 21 | $338 | $16 |
| Levetiracetam Er | None | 13 | $290 | $22 |
2022: 24 drugs
| Gamunex-C | Immune globulin | 24 | $81,459 | $3,394 |
| Keppra Xr | None | 12 | $7,265 | $605 |
| Dimethyl | None | 13 | $7,097 | $546 |
| Rytary | Parkinson's | 19 | $6,958 | $366 |
| Rivastigmine | None | 54 | $5,951 | $110 |
| Memantine | None | 86 | $5,573 | $65 |
| Duloxetine | None | 37 | $3,624 | $98 |
| Galantamine Hbr | None | 26 | $3,159 | $122 |
| Pregabalin | None | 55 | $3,077 | $56 |
| Carbidopa-Levodopa | None | 13 | $2,004 | $154 |
| Quetiapine | None | 11 | $1,555 | $141 |
| Ramelteon | None | 12 | $1,530 | $128 |
| Venlafaxine Hcl Er | None | 21 | $1,381 | $66 |
| Gabapentin | None | 85 | $1,247 | $15 |
| Levetiracetam | None | 33 | $966 | $29 |
| Levetiracetam Er | None | 14 | $802 | $57 |
| Divalproex | None | 39 | $767 | $20 |
| Primidone | None | 17 | $766 | $45 |
| Rizatriptan | None | 14 | $544 | $39 |
| Cyclobenzaprine | None | 14 | $446 | $32 |
| Donepezil | None | 27 | $344 | $13 |
| Escitalopram | None | 42 | $317 | $8 |
| Lamotrigine | None | 15 | $269 | $18 |
| Atorvastatin | None | 20 | $225 | $11 |
2021: 16 drugs
| Eliquis | 12 | $8,448 | $704 |
| Rivastigmine | 69 | $6,059 | $88 |
| Ramelteon | 19 | $3,861 | $203 |
| Memantine | 73 | $3,447 | $47 |
| Pregabalin | 45 | $3,140 | $70 |
| Levetiracetam Er | 28 | $2,411 | $86 |
| Galantamine Hbr | 22 | $2,226 | $101 |
| Gabapentin | 61 | $1,249 | $20 |
| Carbidopa-Levodopa | 11 | $847 | $77 |
| Divalproex | 35 | $834 | $24 |
| Venlafaxine Hcl Er | 17 | $568 | $33 |
| Atorvastatin | 21 | $274 | $13 |
| Escitalopram | 36 | $205 | $6 |
| Duloxetine | 12 | $202 | $17 |
| Topiramate | 11 | $163 | $15 |
| Clonazepam | 11 | $158 | $14 |
2020: 16 drugs
| Rivastigmine | 14 | $6,221 | $444 |
| Rivastigmine | 31 | $3,942 | $127 |
| Galantamine Er | 17 | $3,905 | $230 |
| Galantamine Hbr | 19 | $3,736 | $197 |
| Pregabalin | 47 | $2,428 | $52 |
| Levetiracetam Er | 17 | $1,838 | $108 |
| Memantine | 43 | $1,833 | $43 |
| Gabapentin | 40 | $691 | $17 |
| Levetiracetam | 21 | $582 | $28 |
| Primidone | 18 | $528 | $29 |
| Rizatriptan | 11 | $388 | $35 |
| Topiramate | 12 | $275 | $23 |
| Atorvastatin | 13 | $220 | $17 |
| Quetiapine | 13 | $210 | $16 |
| Escitalopram | 41 | $202 | $5 |
| Divalproex | 18 | $201 | $11 |
2019: 15 drugs
| Lyrica | 27 | $13,473 | $499 |
| Rivastigmine | 27 | $5,811 | $215 |
| Eliquis | 11 | $4,942 | $449 |
| Galantamine Hbr | 18 | $1,836 | $102 |
| Galantamine Er | 12 | $1,563 | $130 |
| Rivastigmine | 11 | $1,083 | $98 |
| Memantine | 13 | $879 | $68 |
| Gabapentin | 58 | $878 | $15 |
| Pregabalin | 13 | $657 | $51 |
| Escitalopram | 35 | $517 | $15 |
| Topiramate | 23 | $378 | $16 |
| Clonazepam | 12 | $273 | $23 |
| Levetiracetam | 12 | $227 | $19 |
| Quetiapine | 19 | $217 | $11 |
| Trazodone | 12 | $164 | $14 |
2018: 2 drugs
| Gabapentin | 45 | $539 | $12 |
| Donepezil | 23 | $283 | $12 |
2017: 29 drugs
| Copaxone | 22 | $150,220 | $6,828 |
| Vimpat | 30 | $29,942 | $998 |
| Divalproex | 47 | $8,077 | $172 |
| Oxcarbazepine | 26 | $7,903 | $304 |
| Tegretol | 13 | $6,812 | $524 |
| Levetiracetam | 130 | $5,717 | $44 |
| Carbamazepine | 44 | $4,867 | $111 |
| Carbamazepine Er | 24 | $3,878 | $162 |
| Rivastigmine | 16 | $2,277 | $142 |
| Dilantin | 16 | $2,231 | $139 |
| Gabapentin | 104 | $2,228 | $21 |
| Pyridostigmine | 23 | $2,141 | $93 |
| Divalproex Sodium Er | 13 | $2,138 | $164 |
| Carbidopa-Levodopa | 51 | $2,082 | $41 |
| Amantadine | 18 | $1,523 | $85 |
| Lamotrigine | 66 | $1,456 | $22 |
| Phenobarbital | 31 | $1,120 | $36 |
| Ropinirole | 29 | $773 | $27 |
| Memantine | 15 | $644 | $43 |
| Topiramate | 35 | $557 | $16 |
| Baclofen | 16 | $400 | $25 |
| Zonisamide | 16 | $362 | $23 |
| Clonazepam | 49 | $292 | $6 |
| Primidone | 19 | $264 | $14 |
| Fludrocortisone Acetate | 12 | $246 | $20 |
| Donepezil | 25 | $132 | $5 |
| Nortriptyline | 12 | $116 | $10 |
| Escitalopram | 11 | $113 | $10 |
| Lorazepam | 12 | $45 | $4 |
2016: 45 drugs
| Copaxone | 15 | $130,113 | $8,674 |
| Tecfidera | 12 | $86,619 | $7,218 |
| Vimpat | 85 | $61,779 | $727 |
| Lyrica | 22 | $14,633 | $665 |
| Potiga | 11 | $11,624 | $1,057 |
| Carbamazepine | 109 | $11,330 | $104 |
| Divalproex | 88 | $10,440 | $119 |
| Levetiracetam | 241 | $9,499 | $39 |
| Divalproex Sodium Er | 38 | $6,940 | $183 |
| Carbamazepine Er | 34 | $6,448 | $190 |
| Amantadine | 52 | $6,013 | $116 |
| Tegretol | 13 | $5,989 | $461 |
| Exelon | 11 | $5,709 | $519 |
| Oxcarbazepine | 46 | $4,920 | $107 |
| Dilantin | 32 | $4,390 | $137 |
| Gabapentin | 196 | $4,292 | $22 |
| Carbidopa-Levodopa Er | 33 | $3,568 | $108 |
| Pyridostigmine | 29 | $3,253 | $112 |
| Carbidopa-Levodopa | 99 | $2,771 | $28 |
| Lamotrigine | 159 | $2,569 | $16 |
| Duloxetine | 19 | $2,349 | $124 |
| Phenobarbital | 57 | $2,022 | $35 |
| Phenytoin Sodium Extended | 41 | $1,652 | $40 |
| Zonisamide | 66 | $1,515 | $23 |
| Donepezil | 56 | $1,444 | $26 |
| Midodrine | 16 | $1,348 | $84 |
| Ropinirole | 44 | $1,105 | $25 |
| Memantine | 13 | $1,064 | $82 |
| Topiramate | 66 | $1,037 | $16 |
| Propranolol | 34 | $964 | $28 |
| Primidone | 55 | $626 | $11 |
| Nortriptyline | 46 | $482 | $10 |
| Doxepin | 12 | $395 | $33 |
| Risperidone | 16 | $366 | $23 |
| Clonazepam | 73 | $341 | $5 |
| Ondansetron | 11 | $316 | $29 |
| Fludrocortisone Acetate | 13 | $310 | $24 |
| Ipratropium | 12 | $288 | $24 |
| Baclofen | 23 | $281 | $12 |
| Amitriptyline | 13 | $213 | $16 |
| Rizatriptan | 12 | $207 | $17 |
| Paroxetine | 15 | $187 | $12 |
| Polyethylene Glycol 3350 | 14 | $136 | $10 |
| Mirtazapine | 13 | $116 | $9 |
| Lorazepam | 25 | $83 | $3 |
2015: 29 drugs
| Vimpat | 42 | $24,608 | $586 |
| Lyrica | 18 | $9,147 | $508 |
| Entacapone | 15 | $8,347 | $556 |
| Carbamazepine | 55 | $4,631 | $84 |
| Levetiracetam | 108 | $4,381 | $41 |
| Carbidopa-Levodopa | 80 | $3,286 | $41 |
| Gabapentin | 96 | $2,487 | $26 |
| Amantadine | 19 | $2,273 | $120 |
| Lamotrigine | 66 | $2,061 | $31 |
| Divalproex Sodium Er | 13 | $1,988 | $153 |
| Oxcarbazepine | 21 | $1,624 | $77 |
| Divalproex | 33 | $1,259 | $38 |
| Carbidopa-Levodopa Er | 19 | $997 | $52 |
| Duloxetine | 13 | $831 | $64 |
| Phenytoin Sodium Extended | 16 | $711 | $44 |
| Phenobarbital | 18 | $705 | $39 |
| Ropinirole | 11 | $665 | $60 |
| Propranolol | 24 | $607 | $25 |
| Topiramate | 36 | $483 | $13 |
| Pramipexole Dihydrochloride | 14 | $453 | $32 |
| Zonisamide | 23 | $401 | $17 |
| Doxepin | 15 | $317 | $21 |
| Amitriptyline | 13 | $297 | $23 |
| Primidone | 18 | $216 | $12 |
| Clonazepam | 35 | $210 | $6 |
| Nortriptyline | 21 | $179 | $9 |
| Donepezil | 25 | $170 | $7 |
| Prednisone | 11 | $117 | $11 |
| Lorazepam | 25 | $82 | $3 |
2014: 13 drugs
| Gabapentin | 69 | $3,140 | $46 |
| Levetiracetam | 41 | $2,810 | $69 |
| Carbamazepine Xr | 24 | $2,746 | $114 |
| Tizanidine | 17 | $1,510 | $89 |
| Lamotrigine | 28 | $1,349 | $48 |
| Lidocaine-Prilocaine | 13 | $1,065 | $82 |
| Pyridostigmine | 14 | $907 | $65 |
| Zonisamide | 13 | $279 | $21 |
| Donepezil | 13 | $217 | $17 |
| Baclofen | 14 | $207 | $15 |
| Topiramate | 24 | $96 | $4 |
| Prednisone | 22 | $94 | $4 |
| Fluoxetine | 13 | $21 | $2 |
2013: 18 drugs
| Gabapentin | 54 | $4,809 | $89 |
| Carbamazepine Xr | 22 | $2,603 | $118 |
| Lyrica | 13 | $1,769 | $136 |
| Sumatriptan | 18 | $1,560 | $87 |
| Lidocaine-Prilocaine | 15 | $1,449 | $97 |
| Levetiracetam | 20 | $1,225 | $61 |
| Divalproex Sodium Er | 13 | $1,141 | $88 |
| Pyridostigmine | 16 | $974 | $61 |
| Topiramate | 35 | $877 | $25 |
| Carbamazepine | 11 | $813 | $74 |
| Lamotrigine | 19 | $759 | $40 |
| Phenytoin Sodium Extended | 13 | $609 | $47 |
| Donepezil | 12 | $230 | $19 |
| Zonisamide | 13 | $188 | $14 |
| Baclofen | 18 | $183 | $10 |
| Prednisone | 19 | $116 | $6 |
| Nortriptyline | 11 | $110 | $10 |
| Fluoxetine | 17 | $46 | $3 |
Money from drug and device companies
$127 in 2025
| 2025 | 1 | 1 | None | $127 |
| 2024 | 1 | 1 | None | $124 |
| 2023 | 4 | 4 | None | $287 |
| 2022 | 3 | 4 | $1,305 | $1,318 |
| 2021 | 1 | 1 | None | $13 |
| 2020 | 2 | 2 | $333 | $353 |
| 2019 | 2 | 2 | $379 | $602 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| SK Life Science | Xcopri | $127 | 1 payment
|
See the published payment
| SK Life Science | Meals · 2025-12-11 | Xcopri | $127 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $124
| Eisai | Leqembi | $124 | 1 payment
|
2023: $287
| SK Life Science | Xcopri | $122 | 1 payment
|
| Cala Health | Cala Trio | $106 | 1 payment
|
| Eisai | Leqembi | $40 | 1 payment
|
| Nevro | Senza | $19 | 1 payment
|
2022: $1,318
| ZOLL Medical | None | $956 | 2 payments
|
| Amneal Pharmaceuticals | None | $349 | 1 payment
|
| Impel Pharmaceuticals | Trudhesa | $12 | 1 payment
|
2021: $13
| Novartis Pharmaceuticals | Kesimpta | $13 | 1 payment
|
2020: $353
| Pacira Pharmaceuticals | Exparel | $333 | 1 payment
|
| Nevro | Senza Spinal Cord Stimulation System | $20 | 1 payment
|
2019: $602
| Dr.Reddy's Laboratories | None | $379 | 1 payment
|
| Boston Scientific | Spectra Wavewriter | $223 | 1 payment
|
Professional record
- NPI
- 1326269515
- Licence
- IL 125-052048Illinois 125052048: Expired
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- IL 036127669
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-05-02
- NPI last updated
- 2020-06-23
- NPI record certified
- 2020-06-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 N Rutledge St, Springfield, IL, 62702